Wednesday, 9 May 2018

FDA says Mylan's EpiPen is in shortage in U.S.

(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy treatment.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)